학술논문
Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
Document Type
Article
Author
Kiladjian, Jean-Jacques ; Zachee, Pierre; Hino, Masayuki; Pane, Fabrizio; Masszi, Tamas; Harrison, Claire N; Mesa, Ruben; Miller, Carole B; Passamonti, Francesco; Durrant, Simon; Griesshammer, Martin; Kirito, Keita; Besses, Carlos; Moiraghi, Beatriz; Rumi, Elisa; Rosti, Vittorio; Blau, Igor Wolfgang; Francillard, Nathalie; Dong, Tuochuan; Wroclawska, Monika; Vannucchi, Alessandro M; Verstovsek, Srdan
Source
In The Lancet Haematology March 2020 7(3):e226-e237
Subject
Language
ISSN
2352-3026